The search for better immunotherapy biomarkers is forcing the field to reconsider how it classifies cancers, with implications for the next wave of combination studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Kingwell, K. Biomarker search illuminates cancer immune biology. Nat Rev Drug Discov 15, 443–445 (2016). https://doi.org/10.1038/nrd.2016.131
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.131